Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Oct 1, 2021

Accession no.
0001209191-21-058527
Filed
Oct 1, 2021
Trade date
Sep 1-30, 2021
Filing delay
30 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $2.50K. It was filed 30 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2021Common StockPPurchaseAcquired+42$2.88+$120.9616,338Direct
Sep 2, 2021Common StockPPurchaseAcquired+42$2.88+$120.9616,380Direct
Sep 3, 2021Common StockPPurchaseAcquired+42$2.85+$119.716,422Direct
Sep 7, 2021Common StockPPurchaseAcquired+42$2.79+$117.1816,464Direct
Sep 8, 2021Common StockPPurchaseAcquired+42$2.89+$121.3816,506Direct
Sep 9, 2021Common StockPPurchaseAcquired+42$2.77+$116.3416,548Direct
Sep 10, 2021Common StockPPurchaseAcquired+42$2.78+$116.7616,590Direct
Sep 13, 2021Common StockPPurchaseAcquired+42$2.96+$124.3216,632Direct
Sep 14, 2021Common StockPPurchaseAcquired+42$3.02+$126.8416,674Direct
Sep 15, 2021Common StockPPurchaseAcquired+42$2.86+$120.1216,716Direct
Sep 16, 2021Common StockPPurchaseAcquired+42$2.91+$122.2216,758Direct
Sep 17, 2021Common StockPPurchaseAcquired+42$2.85+$119.716,800Direct
Sep 20, 2021Common StockPPurchaseAcquired+42$2.82+$118.4416,842Direct
Sep 21, 2021Common StockPPurchaseAcquired+42$2.81+$118.0216,884Direct
Sep 22, 2021Common StockPPurchaseAcquired+42$2.76+$115.9216,926Direct
Sep 23, 2021Common StockPPurchaseAcquired+42$2.75+$115.516,968Direct
Sep 24, 2021Common StockPPurchaseAcquired+42$2.74+$115.0817,010Direct
Sep 27, 2021Common StockPPurchaseAcquired+42$2.79+$117.1817,052Direct
Sep 28, 2021Common StockPPurchaseAcquired+42$2.76+$115.9217,094Direct
Sep 29, 2021Common StockPPurchaseAcquired+42$2.82+$118.4417,136Direct
Sep 30, 2021Common StockPPurchaseAcquired+42$2.72+$114.2417,178Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)